Citations

Clear

3942 citation(s) found for "To, Van".

European guidelines on chronic mesenteric ischaemia – joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepat
Terlouw, Luke G. , Moelker, Adriaan , Abrahamsen, Jan , Acosta, Stefan , Bakker, Olaf J. , Baumgärtner, Iris , Boyer, L. , Dijk, Louisa J.D. van , Duran, Mansur , Jackson, Ralph, Oderich, Gustavo S. , Kolkman, Jeroen J. , Nuzzo, Alexandre , Raupach, Jan , Zech, Christoph J. , Noord, Desirée van , Bruno, Marco J. , van Dijk, Louisa Jd , Geelkerken, Robert H , Kärkkäinen, Jussi M, Zech, Christoph J , Corcos, Olivier , Illuminati, Giulio , Kärkkäinen, Jussi M. , Lönn, Lars , Mazzei, Maria Antonietta , Pecoraro, Felice , Verhagen, Hence J.M.

Mayo Clinic

United European Gastroenterology Journal | April 16, 2020 | Volume: 8 | Issue: 4 | Pages: 371-395

10.1177/2050640620916681 | PMID 32297566 Get It

Chronic mesenteric ischaemia is a severe and incapacitating disease, causing complaints of post‐prandial pain, fear of eating and weight loss. Even though chronic mesenteric ischaemia may progress to acute mesenteric ischaemia, chronic mesenteric ischaemia remains an underappreciated and undertreated disease entity. Probable explanations are the lack of knowledge and awareness among physicians and the lack of a gold standard diagnostic test. The underappreciation of this disease results in diagnostic delays, underdiagnosis and undertreating of patients with chronic mesenteric ischaemia, potentially resulting in fatal acute mesenteric ischaemia. This guideline provides a comprehensive overview and repository of the current evidence and multidisciplinary expert agreement on pertinent issues regarding diagnosis and treatment, and provides guidance in the multidisciplinary field of chronic mesenteric ischaemia.
Epigenetic Control of Osteoblast Differentiation by Chromobox 3 (Cbx3) Protein 3
Bagheri, Leila, Thaler, Roman , Badreldin, Amr A. , Khani, Farzaneh , Deyle, David R. , Pengfei, Zan, Milbrandt, Todd A. , Dudakovic, Amel , Wijnen, André J. van , van Wijnen, Andre J , Paradise, Christopher R. , Larson, A. Noelle

Mayo Clinic

The FASEB Journal | April 15, 2020 | Volume: 34 | Issue: S1 | Pages: 1-1

10.1096/fasebj.2020.34.s1.00547 Get It

Skeletal development is controlled by epigenetic mechanisms that regulate chromatin compaction and suppress access to gene regulatory sequences. Post‐translational modifications in the N‐termini of histone 3 (H3), including tri‐methylated H3 lysine 9 (H3K9Me3) or lysine 27 (H3K27Me3) represent repressive chromatin marks that are recognized by a family of heterochromatin‐associated Chromobox (Cbx) proteins (i.e., Cbx1 to Cbx8). We show using RNA‐seq analysis that each of these Cbx isoforms is actively expressed in bone and osteoblasts with variable expression of distinct members (between 1 and 100 reads per million). The most prominently expressed Cbx member is Cbx3, which encodes a member of the heterochromatin protein 1 (HP1) family that interacts with H3K9me3. Cbx3 is known to be important for normal development while promoting neurogenesis, as well as renal and smooth muscle development. Therefore, we postulated that CBx3 may perform a similar role in osteoblastogenesis. We tested this hypothesis by both transient and stable knock‐down of Cbx3 by respectively siRNA or shRNA. RNA interference in MC3T3 osteoblasts effectively decreases Cbx3 mRNA levels by 2 to 5 fold, while increasing expression of bone‐related markers by RT‐qPCR (e.g., Alpl/alkaline phosphatase, Ibsp/bone sialoprotein, Bglap/osteocalcin, and Col1a1/Collagen Type I α1 chain). In addition, Cbx3 depletion increases mineral deposition as measured by Alizarin Red staining. Thus, Cbx3 normally appears to suppress osteoblastic differentiation, unlike its essential function in the neuronal differentiation. Because Cbx3 recognizes H3K9me3, we examined whether Cbx3 controls the levels of this histone mark. Loss of Cbx3 did not affect total H3K9me3 levels unless Cbx1 and Cbx5 were simultaneously depleted by siRNA. We propose that Cbx3 may suppress osteoblastogenesis by controlling select loci with H3K9me3 marks.
Sorting nexin 1 loss results in increased oxidative stress and hypertension
Yang, Jian , Asico, Laureano D. , Beitelshees, Amber L. , Feranil, Jun, Wang, Xiaoyan , Jones, John E., Armando, Inés , Cuevas, Santiago , Schwartz, Gary L. , Gums, John G. , Chapman, Arlene B. , Boerwinkle, Eric , Johnson, Julie A. , Felder, Robin A. , Weinman, Edward J., Zeng, Chunyu , José, Pedro A. , Villar, Van Anthony M., Beitelshees, Amber L. , Turner, Stephen T. , Chapman, Arlene B. , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

The FASEB Journal | April 15, 2020 | Volume: 34 | Issue: 6 | Pages: 7941-7957

10.1096/fj.201902448r | PMID 32293069 Get It

Abstract Acute renal depletion of sorting nexin 1 (SNX1) in mice results in blunted natriuretic response and hypertension due to impaired dopamine D 5 receptor (D 5 R) activity. We elucidated the molecular mechanisms for these phenotypes in Snx1 −/− mice. These mice had increased renal expressions of angiotensin II type 1 receptor (AT 1 R), NADPH oxidase (NOX) subunits, D 5 R, and NaCl cotransporter. Basal reactive oxygen species (ROS), NOX activity, and blood pressure (BP) were also higher in Snx1 ‐/‐ mice, which were normalized by apocynin, a drug that prevents NOX assembly. Renal proximal tubule (RPT) cells from hypertensive (HT) Euro‐American males had deficient SNX1 activity, impaired D 5 R endocytosis, and increased ROS compared with cells from normotensive (NT) Euro‐American males. siRNA‐mediated depletion of SNX1 in RPT cells from NT subjects led to a blunting of D 5 R agonist‐induced increase in cAMP production and decrease in Na + transport, effects that were normalized by over‐expression of SNX1. Among HT African‐Americans, three of the 12 single nucleotide polymorphisms interrogated for the SNX1 gene were associated with a decrease in systolic BP in response to hydrochlorothiazide (HCTZ). The results illustrate a new paradigm for the development of hypertension and imply that the trafficking protein SNX1 may be a crucial determinant for hypertension and response to antihypertensive therapy.
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
Bellomo, Domenico , Arias‐Mejias, Suzette M. , Ramana, Chandru, Heim, Joel B. , Quattrocchi, Enrica , Sominidi‐Damodaran, Sindhuja , Bridges, Alina G. , Lehman, Julia S. , Jakub, James W. , Pittelkow, Mark R. , DiCaudo, David J. , Pockaj, Barbara A. , Sluzevich, Jason C. , Cappel, Mark A. , Perniciaro, Charles , Tjien-Fooh, Félicia , Vliet, Martin H. van , Dwarkasing, Jvalini, Meves, Alexander , Lehman, Julia S , Jakub, James W , Sluzevich, Jason C , Heim, Joel B , Hieken, Tina J. , Bagaria, Sanjay P.

Mayo Clinic

JCO Precision Oncology | April 14, 2020 | Volume: No volume available | Issue: 4 | Pages: 319-334

10.1200/po.19.00206 | PMID 32405608 Get It

PURPOSEMore than 80% of patients who undergo sentinel lymph node (SLN) biopsy have no nodal metastasis. Here, we describe a model that combines clinicopathologic and molecular variables to identify patients with thin- and intermediate-thickness melanomas who may forgo the SLN biopsy procedure because of their low risk of nodal metastasis.PATIENTS AND METHODSGenes with functional roles in melanoma metastasis were discovered by analysis of next-generation sequencing data and case-control studies. We then used polymerase chain reaction to quantify gene expression in diagnostic biopsy tissue across a prospectively designed archival cohort of 754 consecutive thin- and intermediate-thickness primary cutaneous melanomas. Outcome of interest was SLN biopsy metastasis within 90 days of melanoma diagnosis. A penalized maximum likelihood estimation algorithm was used to train logistic regression models in a repeated cross-validation scheme to predict the presence of SLN metastasis from molecular, clinical, and histologic variables.RESULTSExpression of genes with roles in epithelial-to-mesenchymal transition (glia-derived nexin, growth differentiation factor 15, integrin-β3, interleukin 8, lysyl oxidase homolog 4, transforming growth factor-β receptor type 1, and tissue-type plasminogen activator) and melanosome function (melanoma antigen recognized by T cells 1) were associated with SLN metastasis. The predictive ability of a model that only considered clinicopathologic or gene expression variables was outperformed by a model that included molecular variables in combination with the clinicopathologic predictors Breslow thickness and patient age (area under the receiver operating characteristic curve, 0.82; 95% CI, 0.78 to 0.86; SLN biopsy reduction rate, 42%; negative predictive value, 96%).CONCLUSIONA combined model that included clinicopathologic and gene expression variables improved the identification of patients with melanoma who may forgo the SLN biopsy procedure because of their low risk of nodal metastasis.
Cholinergic neuroplasticity in asthma driven by TrkB signaling
Dragunas, Guilherme , Woest, Manon E., Nijboer, Susan, Bos, Sophie, Asselt, Janet, Groot, Anne P. de , Vohlídalová, Eva, Vermeulen, Corneel J., Ditz, Benedikt , Koppelman, Gerard H. , Berge, Maarten van den , Hacken, Nick H.T. ten , Timens, Wim , Munhoz, Carolina Demarchi , Prakash, Y. S. , Gosens, Reinoud , Kistemaker, Loes , Prakash, Y S , Gosens, Reinoud , Timens, Wim , Vermeulen, Cornelis Joseph , Vonk, Judith M.

Mayo Clinic

The FASEB Journal | April 11, 2020 | Volume: 34 | Issue: 6 | Pages: 7703-7717

10.1096/fj.202000170r | PMID 32277855 Get It

Abstract Parasympathetic neurons in the airways control bronchomotor tone. Increased activity of cholinergic neurons are mediators of airway hyperresponsiveness (AHR) in asthma, however, mechanisms are not elucidated. We describe remodeling of the cholinergic neuronal network in asthmatic airways driven by brain‐derived neurotrophic factor (BDNF) and Tropomyosin receptor kinase B ( TrkB). Human bronchial biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT). Human lung gene expression and single nucleotide polymorphisms (SNP) in neuroplasticity‐related genes were compared between asthma and healthy patients. Wild‐type (WT) and mutated TrkB knock‐in mice (Ntrk2tm1Ddg/J) with impaired BDNF signaling were chronically exposed to ovalbumin (OVA). Neuronal VAChT staining and airway narrowing in response to electrical field stimulation in precision cut lung slices (PCLS) were assessed. Increased cholinergic fibers in asthmatic airway biopsies was found, paralleled by increased TrkB gene expression in human lung tissue, and SNPs in the NTRK2 [TrkB] and BDNF genes linked to asthma. Chronic allergen exposure in mice resulted in increased density of cholinergic nerves, which was prevented by inhibiting TrkB. Increased nerve density resulted in AHR in vivo and in increased nerve‐dependent airway reactivity in lung slices mediated via TrkB. These findings show cholinergic neuroplasticity in asthma driven by TrkB signaling and suggest that the BDNF‐TrkB pathway may be a potential target.
RanBP2/Nup358 is required for Topoisomerase II/alpha‐mediated DNA decatenation, proper chromosome segregation and tumor suppression
Deursen, Jan MA van, Dawlaty, Meelad M. , Liviu, Malureanu, Jeganathan, Karthik B.

Mayo Clinic

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a210 Get It

RanBP2/Nup358 is a component of the nucleocytoplasmic transport machinery that has been implicated in mitotic progression. To determine the physiological importance of RanBP2 and its role in mitosis we have generated a series of mice with graded reduction of RanBP2 levels. Mice with very low amounts of RanBP2 are viable and overtly normal, but develop severe aneuploidy. Their major mitotic abnormality is the formation of anaphase bridges, a defect linked to improper Topoisomerase II/alpha‐mediated decatenation of sister chromatids. We find that RanBP2 forms a complex with Topoisomerase II/alpha in mitosis and regulates its decatenation activity and localization to chromosomes. Furthermore, we find that RanBP2 deficient mice are prone to spontaneous and carcinogen‐induced tumors. Together, these data identify RanBP2 as a key regulator of Topoisomerase II/alpha‐mediated DNA decatenation and a suppressor of tumorigenesis.
Creating a Flexible Outpatient Mental Health Transitions Program
Larsen, Clare A., McKay, Ann K., Steinburg, Pamela J. Van, Van Steinburg, Pamela J

Mayo Clinic

Issues in Mental Health Nursing | April 10, 2020 | Volume: 41 | Issue: 6 | Pages: 500-505

10.1080/01612840.2019.1681566 | PMID 32275459 Get It

Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience
Cohen-Cohen, Salomón , Wheeler, Lydia , Ruff, Michael W. , Major, Brittny , Ospina, Naykky Singh , Atkinson, John L. D., Meyer, Fredric B. , Ospina, Naykky Singh , Singh Ospina, Naykky , Brown, Desmond , Himes, Benjamin , Bancos, Irina , Young, William F. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | April 9, 2020 | Volume: 134 | Issue: 4 | Pages: 1132-1138

10.3171/2020.1.jns193538 | PMID 32244213 Get It

OBJECTIVE Multiple endocrine neoplasia type 1 (MEN1) is a rare, autosomal-dominant tumor disorder characterized by the development of pituitary tumors and other endocrine neoplasms. Diagnosis is made clinically based on the development of 2 or more canonical lesions (parathyroid gland, anterior pituitary, and enteropancreatic tumors) or in family members of a patient with a clinical diagnosis of MEN1 and the occurrence of one of the MEN1-associated tumors. The goal of this study was to characterize pituitary tumors arising in the setting of MEN1 at a single institution. The probability of tumor progression and the likelihood of surgical intervention in patients with asymptomatic nonfunctional pituitary adenomas were also analyzed. METHODS A retrospective review of a prospectively maintained institutional database was performed for patients with MEN1 diagnosed from 1970 to 2017. Data included patient demographics, tumor characteristics, treatment strategies, and outcomes. RESULTS A review of the database identified 268 patients diagnosed with MEN1, of whom 158 (59%) were female. Among the 268 patients, 139 (51.8%) had pituitary adenomas. There was a higher prevalence in women than in men (65% vs 35%, p < 0.005). Functional adenomas (57%) were more common. Prolactin-secreting adenomas were the most common functional tumors. Macroadenomas were seen in 27% of patients and were more likely to be symptomatic and locally aggressive (p < 0.001). Forty-nine patients (35%) underwent transsphenoidal resection at some point during their disease course. In 52 patients who were initially observed with MEN1 asymptomatic nonfunctional adenomas, only 5 (10%) progressed to need surgery. In MEN1 patients, an initial parathyroid lesion is most likely followed in order by pituitary, pancreatic, adrenal, and, finally, rare carcinoid tumors. CONCLUSIONS Asymptomatic nonfunctional pituitary adenomas in patients with MEN1 may be followed safely with MRI. In this series, parathyroid tumors developed at the lowest median age of all cardinal tumors, and development of additional cardinal MEN1 lesions followed a predictable pattern. This pattern of disease progression could have significant implications for disease surveillance in clinical practice and may help to target clinical resources to the lesions most likely to develop next. This may aid with early detection and treatment and warrants further study.
E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice
Moreno, Eva Venegas , Toussaint, M.J.M., Essen, Saskia C. van, Bongiovanni, Laura , Liere, Elsbeth A. van , Koster, Mirjam H. , Yuan, Ruixue , Deursen, Jan M. van , Westendorp, Bart , Bruin, Alain de , de Bruin, Alain , Moreno, Eva

Mayo Clinic

Hepatology | April 7, 2020 | Volume: 73 | Issue: 1 | Pages: 303-317

10.1002/hep.31259 | PMID 32259305 Get It

Background and Aims Up‐regulation of the E2F‐dependent transcriptional network has been identified in nearly every human malignancy and is an important driver of tumorigenesis. Two members of the E2F family, E2F7 and E2F8, are potent repressors of E2F‐dependent transcription. They are atypical in that they do not bind to dimerization partner proteins and are not controlled by retinoblastoma protein. The physiological relevance of E2F7 and E2F8 remains incompletely understood, largely because tools to manipulate their activity in vivo have been lacking. Approach and Results Here, we generated transgenic mice with doxycycline‐controlled transcriptional activation of E2f7 and E2f8 and induced their expression during postnatal development, in adulthood, and in the context of cancer. Systemic induction of E2f7 and, to lesser extent, E2f8 transgenes in juvenile mice impaired cell proliferation, caused replication stress, DNA damage, and apoptosis, and inhibited animal growth. In adult mice, however, E2F7 and E2F8 induction was well tolerated, yet profoundly interfered with DNA replication, DNA integrity, and cell proliferation in diethylnitrosamine‐induced liver tumors. Conclusion Collectively, our findings demonstrate that atypical E2Fs can override cell‐cycle entry and progression governed by other E2F family members and suggest that this property can be exploited to inhibit proliferation of neoplastic hepatocytes when growth and development have subsided during adulthood.